论文部分内容阅读
美国食品药品管理局已批准应用消炎痛治疗动脉导管未闭。近年美国有13个医学中心协作,研究应用一种可供静脉注射的消炎痛新制剂来治疗动脉导管未闭。当婴儿出生诊断有动脉导管未闭后48小时,如果导管仍
The FDA has approved the use of indomethacin in the treatment of patent ductus arteriosus. In recent years, 13 medical centers in the United States have collaborated to study the application of a new indomethacin formulation for intravenous injection to treat patent ductus arteriosus. When the baby is diagnosed with patent ductus arteriosus 48 hours after the catheter is still in place